Japan: Food and Drugs Law

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Life Science Newsletter April 2025

The Ministry of Health, Labour and Welfare (MHLW) and the Ministry of Economy, Trade and Industry (METI) have revised the Guidelines for New Business Activities in the Healthy Life Extension Industry Sector...

Japan Healthcare

AM

Anderson Mori & Tomotsune

Life Science Newsletter April 2025 (Japanese)

厚生労働省及び経済産業省は、2025 年 3 月 28...

Japan Healthcare

AM

Anderson Mori & Tomotsune

Key Regulatory Considerations For Pharmaceuticals And Medical Devices In Japan

Japan's healthcare market is undergoing a significant transformation driven by an aging population and technological innovation.

Japan Healthcare

Oh-Ebashi LPC & Partners

Publication Of The "Casebook On Antimonopoly Law For Industrial Structural Reform To Ensure Stable Supply Of Generic Drugs"

On February 17, 2025, the Ministry of Health, Labour and Welfare ("MHLW") and the Japan Fair Trade Commission ("JFTC") published the Casebook on Antimonopoly Law for Industrial Structural Reform...

Japan Healthcare

AM

Anderson Mori & Tomotsune

「後発医薬品の安定供給等の実現に向けた産業構造改革のための独占禁止法関係事例集」の公表

Japan Healthcare

AM

Anderson Mori & Tomotsune

Innovative 3D Printing In Healthcare: From Design To Drug Delivery

Japan Healthcare

MC

Marks & Clerk

Life Science Newsletter February 2025 (Japanese)

Japan Healthcare

AM

Anderson Mori & Tomotsune

Life Science Newsletter February 2025

Japan Healthcare

AM

Anderson Mori & Tomotsune

Life Science Newsletter (January 2025)

Japan Healthcare

AM

Anderson Mori & Tomotsune

No Drug? No Dice! Clarifying Orange Book Eligibility For Drug-Device Patents

Japan Healthcare

YMF Law Tokyo

Japan's MHLW Highlights Four Key Themes In Pharmaceuticals And Medical Devices Act Timeline Amendment

Japan Healthcare

RG

Ropes & Gray LLP

Request For Public Comments On The Revised Draft "Guidelines For Distribution Stakeholders To Adhere To For Improving The Distribution Of Medical Pharmaceuticals"

Japan Healthcare

AM

Anderson Mori & Tomotsune

Updates On Drug Regulations In Japan – Reducing Barriers To Entry For Drug Companies Entering The Japanese Market

Japan Healthcare

WS

Winston & Strawn LLP

Overview Of Medical Advertising Regulations

Japan Healthcare

AM

Anderson Mori & Tomotsune

Japan Releases Phase 2 Of Its ¥1 Trillion, 10-year Strategic Space Fund

MC

Marks & Clerk

Restructuring & Insolvency Laws & Regulations Japan 2025

Japan Insolvency

AM

Anderson Mori & Tomotsune

Life Science Newsletter April 2025 (Japanese)

Japan Healthcare

AM

Anderson Mori & Tomotsune

Environmental, Social & Governance Law Japan 2025

Japan Commercial

AM

Anderson Mori & Tomotsune

Introduction Of "Simplified" Type 1 License

AM

Anderson Mori & Tomotsune

Food and Drugs Law

Life Science Newsletter April 2025

The Ministry of Health, Labour and Welfare (MHLW) and the Ministry of Economy, Trade and Industry (METI) have revised the Guidelines for New Business Activities in the Healthy Life Extension Industry Sector...

Japan Healthcare

AM

Anderson Mori & Tomotsune

Key Regulatory Considerations For Pharmaceuticals And Medical Devices In Japan

Japan's healthcare market is undergoing a significant transformation driven by an aging population and technological innovation.

Japan Healthcare

Oh-Ebashi LPC & Partners

Publication Of The "Casebook On Antimonopoly Law For Industrial Structural Reform To Ensure Stable Supply Of Generic Drugs"

On February 17, 2025, the Ministry of Health, Labour and Welfare ("MHLW") and the Japan Fair Trade Commission ("JFTC") published the Casebook on Antimonopoly Law for Industrial Structural Reform...

Japan Healthcare

AM

Anderson Mori & Tomotsune

「後発医薬品の安定供給等の実現に向けた産業構造改革のための独占禁止法関係事例集」の公表

Japan Healthcare

AM

Anderson Mori & Tomotsune

Innovative 3D Printing In Healthcare: From Design To Drug Delivery

Japan Healthcare

MC

Marks & Clerk

Life Science Newsletter (January 2025)

Japan Healthcare

AM

Anderson Mori & Tomotsune

No Drug? No Dice! Clarifying Orange Book Eligibility For Drug-Device Patents

Japan Healthcare

YMF Law Tokyo

Japan's MHLW Highlights Four Key Themes In Pharmaceuticals And Medical Devices Act Timeline Amendment

Japan Healthcare

RG

Ropes & Gray LLP

When It Should Be Obvious That "You Don't Know What You Don't Know"—Salix V. Norwich

YMF Law Tokyo

See more

Life Sciences, Biotechnology & Nanotechnology

Life Science Newsletter April 2025

The Ministry of Health, Labour and Welfare (MHLW) and the Ministry of Economy, Trade and Industry (METI) have revised the Guidelines for New Business Activities in the Healthy Life Extension Industry Sector...

Japan Healthcare

AM

Anderson Mori & Tomotsune

Life Science Newsletter April 2025 (Japanese)

厚生労働省及び経済産業省は、2025 年 3 月 28...

Japan Healthcare

AM

Anderson Mori & Tomotsune

Key Regulatory Considerations For Pharmaceuticals And Medical Devices In Japan

Japan's healthcare market is undergoing a significant transformation driven by an aging population and technological innovation.

Japan Healthcare

Oh-Ebashi LPC & Partners

「後発医薬品の安定供給等の実現に向けた産業構造改革のための独占禁止法関係事例集」の公表

Japan Healthcare

AM

Anderson Mori & Tomotsune

Life Science Newsletter February 2025 (Japanese)

Japan Healthcare

AM

Anderson Mori & Tomotsune

Life Science Newsletter February 2025

Japan Healthcare

AM

Anderson Mori & Tomotsune

Life Science Newsletter (January 2025)

Japan Healthcare

AM

Anderson Mori & Tomotsune

No Drug? No Dice! Clarifying Orange Book Eligibility For Drug-Device Patents

Japan Healthcare

YMF Law Tokyo

Japan's MHLW Highlights Four Key Themes In Pharmaceuticals And Medical Devices Act Timeline Amendment

Japan Healthcare

RG

Ropes & Gray LLP

See more

Healthcare

Life Science Newsletter April 2025

The Ministry of Health, Labour and Welfare (MHLW) and the Ministry of Economy, Trade and Industry (METI) have revised the Guidelines for New Business Activities in the Healthy Life Extension Industry Sector...

Japan Healthcare

AM

Anderson Mori & Tomotsune

Life Science Newsletter April 2025 (Japanese)

厚生労働省及び経済産業省は、2025 年 3 月 28...

Japan Healthcare

AM

Anderson Mori & Tomotsune

Key Regulatory Considerations For Pharmaceuticals And Medical Devices In Japan

Japan's healthcare market is undergoing a significant transformation driven by an aging population and technological innovation.

Japan Healthcare

Oh-Ebashi LPC & Partners

Publication Of The "Casebook On Antimonopoly Law For Industrial Structural Reform To Ensure Stable Supply Of Generic Drugs"

Japan Healthcare

AM

Anderson Mori & Tomotsune

「後発医薬品の安定供給等の実現に向けた産業構造改革のための独占禁止法関係事例集」の公表

Japan Healthcare

AM

Anderson Mori & Tomotsune

Innovative 3D Printing In Healthcare: From Design To Drug Delivery

Japan Healthcare

MC

Marks & Clerk

Life Science Newsletter (January 2025)

Japan Healthcare

AM

Anderson Mori & Tomotsune

No Drug? No Dice! Clarifying Orange Book Eligibility For Drug-Device Patents

Japan Healthcare

YMF Law Tokyo

Japan's MHLW Highlights Four Key Themes In Pharmaceuticals And Medical Devices Act Timeline Amendment

Japan Healthcare

RG

Ropes & Gray LLP

See more

Latest Videos

See more

Sidharrth Shankar | Indian Healthcare Sector In 2023 And Way Forward In 2024 (Video)

J

JSA

How To Export Cosmetics To Thailand (Video)

TG

Tilleke & Gibbins

India's Attractiveness And Opportunities In Healthcare (Video)

NP

Nexdigm Private Limited

RHTLaw Taylor Wessing Healthcare Life Sciences Industry Group (Video)

RT

RHTLaw Taylor Wessing

TiE Event – My Story With Ajit Nagral (July 06, 2018) (Video)

ND

Nishith Desai Associates

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More